Stocks Health care SLBT
NASDAQ · Health careSL Science Holding Ltd (SLBT)
We have not processed filings for SL Science Holding Ltd yet. This page fills in on its own once we have read them.
What SL Science Holding Ltd does
SL Science Holding Ltd is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SLBT.
Latest SEC filings
What SL Science Holding Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026
- September 1, 2026
- August 27, 2026
- August 14, 2026
- July 31, 2026
- July 10, 2026
- June 18, 2026Activist stake (5% or more) SCHEDULE 13D
- June 18, 2026Annual report (foreign issuer) 20-F · period to June 12, 2026
- June 15, 2026
- March 24, 2026Form 425 filing 425
Questions about SLBT
What does SL Science Holding Ltd do?
SL Science Holding Ltd is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SLBT.
When did SL Science Holding Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 18, 2026. It covers the period to June 12, 2026. Its newest filing of any kind is the foreign issuer update from September 24, 2026.
Similar companies
Follow SLBT
Get an email when SL Science Holding Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow SLBT: get an email when it filesWhere the numbers come from
Financial figures are the values SL Science Holding Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.